ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO1183

Encapsulating Peritoneal Sclerosis After Kidney Transplantation: A Diagnostic Challenge

Session Information

Category: Transplantation

  • 2002 Transplantation: Clinical

Authors

  • Su, Lauren, University of Southern California, Los Angeles, California, United States
  • Taylor, Joseph, University of Southern California, Los Angeles, California, United States
  • Klair, Nathaniel, University of Southern California, Los Angeles, California, United States
  • Nguyen, Matthew Duy Thanh Luyen, University of Southern California, Los Angeles, California, United States
  • Sharma, Neeraj, University of Southern California, Los Angeles, California, United States
Introduction

Encapsulating peritoneal sclerosis (EPS), also known as sclerosing encapsulating peritonitis or “cocoon abdomen,” is a rare but severe complication of long-term peritoneal dialysis (PD). EPS can progress even after discontinuation of PD and may present after kidney transplantation, often leading to delayed diagnosis due to nonspecific gastrointestinal manifestations.

Case Description

We present the case of a 56-year-old woman with systemic lupus erythematosus complicated by biopsy-proven class IV lupus nephritis leading to end-stage kidney disease, who underwent PD for 10 years prior to deceased donor kidney transplantation in February 2020. Two months following transplantation, she developed persistent abdominal fullness, nausea, vomiting, and weight loss. Initial diagnostic evaluation was unrevealing, including normal gastric emptying study, esophagogastroduodenoscopy, and colonoscopy. Antimetabolite therapy was switched from mycophenolate to azathioprine without symptom improvement. One year later, MRI pelvis performed for evaluation of an adnexal mass incidentally demonstrated diffuse nonspecific peritoneal thickening.
Over the ensuing years, she experienced recurrent abdominal pain and obstructive gastrointestinal symptoms requiring multiple hospitalizations. CT abdomen demonstrated dilated jejunal and ileal loops consistent with bowel obstruction. In September 2024, she presented with high-grade small bowel obstruction, and imaging findings were highly suspicious for encapsulating peritoneal sclerosis.
At the time of diagnosis, the disease was considered advanced. Due to progressive frailty, malnutrition, and overall poor functional status, standard therapeutic interventions were no longer considered viable treatment options.

Discussion

This case illustrates the diagnostic difficulty and delayed recognition of EPS after kidney transplantation. The patient experienced recurrent symptoms for nearly four years before a definitive diagnosis was found, at which time the disease was too advanced to consider standard interventions for EPS, such as surgical enterolysis and/or antifibrotic therapy with tamoxifen. Clinicians should maintain a high index of suspicion for EPS in patients with prolonged PD exposure who develop recurrent obstructive gastrointestinal symptoms after transplantation, as earlier recognition may allow timely intervention and potentially improve outcomes.